跳至主要内容
临床试验/NCT02014805
NCT02014805Unknown3 期

A Multi-institutional, Randomized Controlled Trial of Postoperative Conformal Radiotherapy for Stage II-III B Type Thymoma

Chinese Academy of Medical Sciences2 个研究点 分布在 1 个国家目标入组 210 人开始时间: 2013年7月最近更新:
适应症

试验速览

阶段
3 期
入组人数
210
试验地点
2
主要终点
3 year local control rate

研究概览

简要总结

The purpose of this study is to determine whether postoperative conformal radiotherapy are effective in the treatment of Masaoka stage II-III B type thymoma.

详细描述

The role of postoperative radiotherapy in thymoma is controversial. Some retrospective studies were for the radiotherapy, but others were against. However, more inherent biases existed in these trials. Resection, Masaoka stage and pathology were widely accepted as the prognostic factors for thymoma. Furthermore, the frequency of local failure after radical resection was still high in Masaoka stage II-III B type thymoma. With the conformal technique appearing, conformal radiotherapy can escalate the dose without increasing the risk of normal tissue toxicities.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-75, Zubrod-ECOG-WHO 0-2, the interval of surgery to radiotherapy < 2months, Masaoka stage II-III and WHO B type thymoma

排除标准

  • No second primary tumor, no serious comorbidity, no neoadjuvant anticancer treatment, no adjuvant chemotherapy.

结局指标

主要结局

3 year local control rate

时间窗: 3 year after the end of all enrollment

local control: tumor recurrence in the tumor bed 3 year local control rate: number of patients with tumor recurrence in the tumor bed at 3 years

次要结局

  • 3 year failure-free and overall survival(3 year after the end of all enrollment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ye Zhang

Attending physician

Chinese Academy of Medical Sciences

研究点 (2)

Loading locations...

相似试验